By Dan Stanton+, 25-Mar-2014
The US FDA has published guidance of how sponsors should best document the bioavailability of products for investigational new drug applications (INDs) and new drug applications (NDAs).
- Suppliers
ADM 
Antares 
Armor Pharma 
Asahi KASEI 
Ashland 
BASF 
Beneo 
Captisol 
Clariant 
Croda 
DFE Pharma 
Dow 
Excipio Chemicals 
Fuji Chemical 
Gattefossé 
Gangwal 
Indovinya 
Ingredient Pharm 
IOI Oleo 
JRS Pharma 
KLK Oleo 
Lipoid 
Lubrizol Life Science Health 
MAGNESIA 
MEGGLE 
Mingtai Chemical 
Nagase Viita 
Nordic Bioproducts 
pharm-a-spheres 
PMC Isochem 
PQ 
Seppic 
ShinEtsu 
Sigachi 
SPI Pharma 
Südzucker 
Vikram Thermo 
Zerion Pharma 
All4Nutra
- Suppliers
ADM Antares Armor Pharma Asahi KASEI Ashland BASF Beneo Captisol Clariant Croda DFE Pharma Dow Excipio Chemicals Fuji Chemical Gattefossé Gangwal Indovinya Ingredient Pharm IOI Oleo JRS Pharma KLK Oleo Lipoid Lubrizol Life Science Health MAGNESIA MEGGLE Mingtai Chemical Nagase Viita Nordic Bioproducts pharm-a-spheres PMC Isochem PQ Seppic ShinEtsu Sigachi SPI Pharma Südzucker Vikram Thermo Zerion Pharma - All4Nutra
US FDA issues new bioavailability guidelines
Related Posts
